Medicare Part D coverage · nimodipine · RxCUI 1423767
nimodipine 3 MG/ML Oral Solution
Per the CMS 2026 Part D formulary file, nimodipine 3 MG/ML Oral Solution is covered by 1,000 Medicare Part D plans (19.8% of enrollable products), averaging Tier 4.2, with prior authorization required on 5.9% of covering formularies.
- 19.8%
- Plan coverage
- 1,000
- Plans covering
- T4.2
- Avg tier
- 5.9%
- Prior auth required
What the CMS Formulary Data Shows for nimodipine 3 MG/ML Oral Solution
Per the CMS 2026 Part D formulary file, nimodipine 3 MG/ML Oral Solution (RxNorm concept RXCUI 1423767, generic name nimodipine) appears on 17 distinct formulary files spanning 1,000 Medicare Part D plan offerings - 19.8% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.2.
Real-world access to nimodipine 3 MG/ML Oral Solution depends on utilization management as much as tier placement: 5.9% of covering formularies require prior authorization. 0% require step therapy. 52.9% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,005 Part D beneficiaries filled nimodipine 3 MG/ML Oral Solution in 2023, with total plan-and-beneficiary spending of $1,126,640 and an average per-beneficiary annual cost of $1,121.03. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry nimodipine 3 MG/ML Oral Solution today.
Coverage Details
- Formularies covering
- 17
- Plans covering
- 1,000
- Coverage rate
- 19.8%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 5.9% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 52.9% of formularies
2023 Medicare Spending
- Beneficiaries
- 1,005
- Total spending
- $1,126,640
- Avg per beneficiary
- $1,121.03
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering nimodipine 3 MG/ML Oral Solution
26 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
Show the next 6 plans
| Humana Basic Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Value Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Value Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Value Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Value Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
| Humana Value Rx Plan (PDP) | Humana Insurance Co. & Humana Insurance Co. of NY | T5 | No | No | $0 | - |
Medicare Advantage Plans (MA-PD) Covering nimodipine 3 MG/ML Oral Solution
74 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T1 | Yes | $0 | CA |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Health First Rewards H1099-014 (HMO) | Health First Health Plans | T4 | No | $0 | FL |
| Health First SunSaver H1099-016 (HMO) | Health First Health Plans | T4 | No | $0 | FL |
| Health First Complete Care H1099-023 (HMO) | Health First Health Plans | T4 | No | $0 | FL |
| Health First Emerald Plus H1099-024 (HMO) | Health First Health Plans | T4 | No | $0 | FL |
| Health First Premier Access H1099-025 (HMO-POS) | Health First Health Plans | T4 | No | $0 | FL |
| Health First Emerald Plus H1099-026 (HMO) | Health First Health Plans | T4 | No | $0 | FL |
| Health First Premier Access H1099-027 (HMO-POS) | Health First Health Plans | T4 | No | $0 | FL |
| Health First Emerald Plus H1099-028 (HMO) | Health First Health Plans | T4 | No | $0 | FL |
| Health First Value H1099-006 (HMO) | Health First Health Plans | T4 | No | $15.00 | FL |
| Health First Classic H1099-001 (HMO-POS) | Health First Health Plans | T4 | No | $49.40 | FL |
| Select Health Medicare Essential (HMO) | Selecthealth, Inc. | T5 | No | $0 | UT |
| Select Health Medicare Essential (HMO) | Selecthealth, Inc. | T5 | No | $0 | NV |
| Select Health Medicare Dual (HMO D-SNP) | Selecthealth, Inc. | T5 | No | $0 | UT |
| Select Health Medicare Essential (HMO) | Selecthealth, Inc. | T5 | No | $0 | UT |
| Select Health Medicare + Kroger (HMO) | Selecthealth, Inc. | T5 | No | $0 | NV |
| Select Health Medicare + Kroger (HMO) | Selecthealth, Inc. | T5 | No | $0 | UT |
| Select Health Medicare Essential (HMO) | Selecthealth, Inc. | T5 | No | $0 | CO |
Show the next 30 plans
Showing top 50 of 74 plans.
Frequently Asked Questions
Is nimodipine 3 MG/ML Oral Solution covered by Medicare Part D?
Yes, nimodipine 3 MG/ML Oral Solution is covered by 1,000 Medicare Part D plans (19.8% of all Part D formularies).
What tier is nimodipine 3 MG/ML Oral Solution on Medicare Part D plans?
nimodipine 3 MG/ML Oral Solution averages Tier 4.2 across Part D plans, ranging from Tier 1 to Tier 5.
Does nimodipine 3 MG/ML Oral Solution require prior authorization?
5.9% of Part D formularies require prior authorization for nimodipine 3 MG/ML Oral Solution. Step therapy: 0%. Quantity limits: 52.9%.
How much does Medicare spend on nimodipine 3 MG/ML Oral Solution?
In 2023, total Medicare Part D spending on nimodipine 3 MG/ML Oral Solution was $1,126,640, covering 1,005 beneficiaries. The average spend per beneficiary was $1,121.03.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- 0.5 ML peginterferon alfa-2a 0.36 MG/ML Prefilled Syringe [Pegasys] T4.2
- 1 ML etanercept 50 MG/ML Prefilled Syringe [Enbrel] T4.2
- 12 HR fostemsavir 600 MG Extended Release Oral Tablet [Rukobia] T4.2
- {14 (venetoclax 10 MG Oral Tablet [Venclexta]) / 21 (venetoclax 100 MG Oral Tablet [Venclexta]) / 7 (venetoclax 50 MG Oral Tablet [Venclexta]) } Pack [Venclexta Starting Pack] T4.2
- 1.5 ML elapegademase-lvlr 1.6 MG/ML Injection [Revcovi] T4.2
- {16 (tovorafenib 100 MG Oral Tablet [Ojemda]) } Pack [Ojemda 400 MG Once Weekly Carton] T4.2
Similar prior-authorization rate
- naloxone 0.5 MG / pentazocine 50 MG Oral Tablet 5.9% PA
- ethacrynic acid 25 MG Oral Tablet 5.9% PA
- protriptyline hydrochloride 10 MG Oral Tablet 5.8% PA
- ursodiol 200 MG Oral Capsule 5.8% PA
- meropenem 500 MG Injection 6.1% PA
- meropenem 1000 MG Injection 6.1% PA